|
|
||||||||
From the Comprehensive Epilepsy Program, Departments of Neurology (Drs. Benbadis and Tatum) and Neurological Surgery (Drs. Benbadis and Vale), University of South Florida College of Medicine and Tampa General Healthcare.
Address correspondence and reprint requests to Dr. Selim R. Benbadis, Associate Professor, Departments of Neurology & Neurosurgery, University of South Florida College of Medicine, 4 Columbia Drive, Suite 730, Tampa, FL 33606; e-mail: sbenbadi{at}hsc.usf.edu
Article abstractNonpharmacologic options for the treatment of epilepsy include epilepsy surgery, vagus nerve stimulation, and the ketogenic diet. The advantages and limitations of these treatment modalities have been extensively reviewed, but there is no general consensus on when each option should be considered. The authors propose an algorithm based on the type of epilepsy. Generally, nonpharmacologic options should be considered earlyi.e., after the first few drug failures. Because of their good outcome with resective surgery, mesial temporal and lesional neocortical epilepsies should be considered for resection. Conversely, nonlesional neocortical epilepsies are probably best approached with vagus nerve stimulation first. For symptomatic or cryptogenic generalized epilepsies, which are commonly intractable, vagus nerve stimulation and the ketogenic diet appear to be reasonable options to consider before palliative surgery such as corpus callosotomy. Idiopathic (i.e., genetic) generalized epilepsies are only rarely refractory to medications and can be outgrown. In rare cases, vagus nerve stimulation may occasionally play a role in their treatment.
This article has been cited by other articles:
![]() |
C.-C. Chen, P.-C. Chiu, and M.-T. Chen Reinvestigation and Reduction of Polytherapy in Children With Chronic Seizures J Child Neurol, January 1, 2007; 22(1): 15 - 20. [Abstract] [PDF] |
||||
![]() |
M. M. Haglund and D. W. Hochman Furosemide and Mannitol Suppression of Epileptic Activity in the Human Brain J Neurophysiol, August 1, 2005; 94(2): 907 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Wennberg Short term benefit of battery depletion in vagus nerve stimulation for epilepsy J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 939 - 939. [Full Text] |
||||
![]() |
J. B. Renfroe and J. W. Wheless Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy Neurology, September 24, 2002; 59(90064): S26 - 30. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |